Showing results (211-220 of 340) with videos related to
Sort By:
Pageof 34
The Journal of Infectious Diseases|November 29, 2020
Association Between Fatty Liver and Cirrhosis, Hepatocellular Carcinoma, and Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis BJie Li, Hwai-I Yang, Ming-Lun Yeh, et al.Journal of Clinical and Translational Hepatology|November 15, 2024
Surveillance Imaging and GAAD/GALAD Scores for Detection of Hepatocellular Carcinoma in Patients with Chronic HepatitisChung-Feng Huang, Konstantin Kroeniger, Chih-Wen Wang, et al.Hepatology (Baltimore, Md.)|January 22, 2011
Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patientsMing-Lung Yu, Chung-Feng Huang, Jee-Fu Huang, et al.Open Forum Infectious Diseases|September 3, 2020
Viral Interference Between Dengue Virus and Hepatitis C Virus InfectionsPo-Cheng Liang, Kuan-Yu Chen, Chung-Hao Huang, et al.The Kaohsiung Journal of Medical Sciences|September 15, 2010
Viral hepatitis infections in southern Taiwan: a multicenter community-based studyJeng-Fu Yang, Chia-I Lin, Jee-Fu Huang, et al.The Kaohsiung Journal of Medical Sciences|January 16, 2017
A real-world impact of cost-effectiveness of pegylated interferon/ribavarin regimens on treatment-naïve chronic hepatitis C patients in TaiwanPei-Chien Tsai, Ta-Wei Liu, Meng-Hsuan Hsieh, et al.Scientific Reports|March 12, 2016
Elevated on-treatment levels of serum IFN-gamma is associated with treatment failure of peginterferon plus ribavirin therapy for chronic hepatitis CMing-Ying Lu, Ching-I Huang, Chia-Yen Dai, et al.Digestive Diseases and Sciences|November 14, 2019
Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis CPo-Yao Hsu, Cheng-Ting Hsu, Ming-Lun Yeh, et al.Journal of Hepatology|February 17, 2020
Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infectionMing-Lun Yeh, Chung-Feng Huang, Ching-I Huang, et al.Scientific Reports|July 2, 2015
Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trialChen-Hua Liu, Chung-Feng Huang, Chun-Jen Liu, et al.Pageof 34